Date published: 2025-11-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

B020004J07Rik Activators

Chemical activators of PRAME like 17 engage in various biochemical pathways to modulate the activity of this protein. Bisindolylmaleimide I, for instance, inhibits protein kinase C (PKC), a kinase that negatively regulates PRAME like 17 activation. By inhibiting PKC, Bisindolylmaleimide I removes this negative regulation, leading to the activation of PRAME like 17. Similarly, Forskolin raises intracellular cAMP levels, which in turn activate protein kinase A (PKA). Activated PKA can phosphorylate target proteins, including PRAME like 17, resulting in its activation. Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK). The activation of CaMK can then lead to the phosphorylation of PRAME like 17. Another activator, Phorbol 12-myristate 13-acetate (PMA), mimics diacylglycerol (DAG) and activates PKC, which can then phosphorylate and activate PRAME like 17.

In addition to these kinase modulators, activators such as Retinoic acid engage with the retinoic acid receptor (RAR)-mediated signaling pathway to induce modifications of PRAME like 17 that result in its activation. Trichostatin A (TSA) acts as a histone deacetylase (HDAC) inhibitor, modifying chromatin structure around PRAME like 17 to facilitate its activation. Epigallocatechin gallate (EGCG) inhibits DNA methyltransferases, potentially leading to the demethylation of the PRAME like 17 promoter region and its activation. Curcumin downregulates NF-κB, which is a negative regulator of PRAME like 17, thereby promoting its activation. Resveratrol activates sirtuins that may deacetylate proteins within the PRAME like 17 activation pathway. Sodium butyrate also acts as an HDAC inhibitor, leading to hyperacetylation of histones and potentially enhancing the expression of PRAME like 17. Piperlongumine raises levels of reactive oxygen species (ROS), which can activate redox-sensitive pathways to activate PRAME like 17. Lastly, Oltipraz modulates the Keap1-Nrf2 pathway, which can activate genes including PRAME like 17 by inducing the antioxidant response elements (AREs). All these chemicals, through their distinct molecular mechanisms, contribute to the regulation and activation of PRAME like 17.

SEE ALSO...

Items 481 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING